microRNA-185 Inhibits SARS-CoV-2 Infection through the Modulation of the Host’s Lipid Microenvironment

With the emergence of the novel betacoronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there has been an urgent need for the development of fast-acting antivirals, particularly in dealing with different variants of concern (VOC). SARS-CoV-2, like other RNA viruses, depends on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Nadine, Francis, Magen E., Ahmed, Noreen, Kelvin, Alyson A., Pezacki, John Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536008/
https://www.ncbi.nlm.nih.gov/pubmed/37766327
http://dx.doi.org/10.3390/v15091921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536008/
https://www.ncbi.nlm.nih.gov/pubmed/37766327
http://dx.doi.org/10.3390/v15091921

Ejemplares similares